Screening strategies to identify new chemical diversity for drug development to treat kinetoplastid infections

Scientific articles

2 Dec 2025

The development of a global research agenda and individual participant data platform for visceral leishmaniasis: challenges and future opportunities

Parasites & Vectors

Scientific articles

25 Nov 2025

Bidirectional interaction between liposomal amphotericin B pharmacokinetics and parasite dynamics in patients with post-kala-azar dermal leishmaniasis: Potential implications for optimal dosing

Clinical Pharmacology & Therapeutics

Scientific articles

20 Nov 2025

Leishmaniasis

Nature Reviews Disease Primers

Scientific articles

20 Nov 2025

Safety, tolerability and pharmacokinetics of DNDI-6148, a novel agent for leishmaniasis: A randomized, controlled, single ascending dose study in healthy participants

British Journal of Clinical Pharmacology